To Access the Effects of Mucositis in Adults With Dental Implants (implantitis)

This study has been completed.
Sponsor:
Information provided by:
Colgate Palmolive
ClinicalTrials.gov Identifier:
NCT01072201
First received: September 26, 2008
Last updated: September 29, 2010
Last verified: September 2010
Results First Received: September 26, 2008  
Study Type: Interventional
Study Design: Allocation: Randomized;   Endpoint Classification: Efficacy Study;   Intervention Model: Parallel Assignment;   Masking: Single Blind (Subject);   Primary Purpose: Treatment
Condition: Mucositis
Interventions: Drug: Triclosan and Fluoride
Drug: Fluoride

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Total Toothpaste Triclosan/copolymer/Fluoride
Ultrabrite Toothpaste sodium fluoride control(placebo)

Participant Flow:   Overall Study
    Total Toothpaste     Ultrabrite Toothpaste  
STARTED     30     30  
COMPLETED     30     29  
NOT COMPLETED     0     1  
Lost to Follow-up                 0                 1  



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Total Toothpaste Triclosan/copolymer/Fluoride
Ultrabrite Toothpaste sodium fluoride control (placebo)
Total Total of all reporting groups

Baseline Measures
    Total Toothpaste     Ultrabrite Toothpaste     Total  
Number of Participants  
[units: participants]
  30     30     60  
Age  
[units: participants]
     
<=18 years     0     0     0  
Between 18 and 65 years     26     26     52  
>=65 years     4     4     8  
Age  
[units: years]
Mean ± Standard Deviation
  57.36  ± 7.38     57.83  ± 7.97     57.59  ± 7.61  
Gender  
[units: participants]
     
Female     20     21     41  
Male     10     9     19  
Region of Enrollment  
[units: participants]
     
Italy     30     30     60  



  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Bleeding on Probing   [ Time Frame: 6 months ]

2.  Primary:   Mean Pocket Depth   [ Time Frame: 6 Months ]

3.  Primary:   Mean Percentage of Plaque Scores   [ Time Frame: 6 Months ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
The agreement is:
unchecked The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
unchecked Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.


Results Point of Contact:  
Name/Title: William De Vizio, DMD
Organization: Colgate Palmolive Co
phone: 732-878-7901
e-mail: William_Devizio@colpal.com


No publications provided


Responsible Party: William DeVizio/VP - Clinical Research, Colgate Palmolive
ClinicalTrials.gov Identifier: NCT01072201     History of Changes
Other Study ID Numbers: CRO-0107-PERIO-MUC-ITA-PC
Study First Received: September 26, 2008
Results First Received: September 26, 2008
Last Updated: September 29, 2010
Health Authority: United States: Food and Drug Administration